THE FDA HAS APPROVED A DRUG AGAINST NIEMANN–PICK DISEASE, TYPE C
For citations:
THE FDA HAS APPROVED A DRUG AGAINST NIEMANN–PICK DISEASE, TYPE C. Pediatric pharmacology. 2024;21(5):468. (In Russ.)
JATS XML
THE FDA HAS APPROVED A DRUG AGAINST NIEMANN–PICK DISEASE, TYPE C. Pediatric pharmacology. 2024;21(5):468. (In Russ.)